← Back to Patent Explorer
US4252822A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for treating phenylketonuria

Assignee: Cincinnati Children's Hospital Medical Center
•
Filing: 1979-12-26
•
Granted: 1981-02-24
•
Expires: 1999-12-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for improving motor and cognitive functions in mammalian subjects affected with phenylketonuria by administering a mixture of valine, isoleucine and leucine as a supplement to the restriction of phenylalanine content of their diets. The invention described herein was made in the course of work under a grant from the Department of Health, Education and Welfare.

Inventors

  • 👤 Helen K. Berry

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 16:00
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/01; A23; A23L; A23L33/00; A23L33/10; A23L33/17; A23L33/175

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 56 words
Method of improving motor and cognitive functions in mammalian subjects afflicted with phenylketonuria by administering to said subjects a mixture consisting essentially of valine, isoleucine and leucine in a total effective amount of said mixture to improve motor and cognitive functions wherein each ingredient is present in an amount to improve said motor and cognitive functions.
Claim 2
Dependent Claim 56 words
Method of improving motor and cognitive functions in mammalian subjects afflicted with phenylketonuria by administering to said subjects a mixture consisting essentially of valine, isoleucine and leucine in a total effective amount of said mixture to improve motor and cognitive functions wherein each ingredient is present in an amount to improve said motor and cognitive functions.
Claim 3
Dependent Claim 15 words
The method of claim 1 wherein the afflicted subject is on a restricted phenylalanine diet.
Claim 4
Dependent Claim 15 words
The method of claim 1 wherein the mixture consists essentially of L-valine, L-isoleucine and L-leucine.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein said administration is conducted orally.
Claim 6
Dependent Claim 17 words
The method of claim 1 wherein the ratio of valine, isoleucine and leucine is about 1:1:1, respectively.
Claim 7
Dependent Claim 27 words
The method of claim 1 wherein the ratio of valine, isoleucine and leucine is in a range of about 1 to about 0.5:1.5 to about 1:2, respectively.
Claim 8
Independent Claim 49 words
The method of improving motor and cognitive functions in humans afflicted with phenylketonuria by orally administering to said subjects a mixture consisting essentially of L-valine, L-isoleucine and L-leucine in a ratio of about 1:1:1, respectively, in a total effective amount of said mixture to improve motor and cognitive functions.
Claim 9
Independent Claim 49 words
The method of improving motor and cognitive functions in humans afflicted with phenylketonuria by orally administering to said subjects a mixture consisting essentially of L-valine, L-isoleucine and L-leucine in a ratio of about 1:1:1, respectively, in a total effective amount of said mixture to improve motor and cognitive functions.
Claim 10
Dependent Claim 20 words
The method of claim 7 wherein said total effective amount is in the range of about 150 to 900 mg/kg.

References Cited (Backward Citations)

US3832465A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-02-24 1984-08-25 1985-02-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-02-24 1988-08-25 1989-02-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-02-24 1992-08-25 1993-02-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag